Literature DB >> 11349813

Differentiation of delta, mu, and kappa opioid receptor agonists based on pharmacophore development and computed physicochemical properties.

M Filizola1, H O Villar, G H Loew.   

Abstract

Compounds that bind with significant affinity to the opioid receptor types, delta, mu, and kappa, with different combinations of activation and inhibition at these three receptors could be promising behaviorally selective agents. Working on this hypothesis, the chemical moieties common to three different sets of opioid receptor agonists with significant affinity for each of the three receptor types delta, mu, or kappa were identified. Using a distance analysis approach, common geometric arrangements of these chemical moieties were found for selected delta, mu, or kappa opioid agonists. The chemical and geometric commonalities among agonists at each opioid receptor type were then compared with a non-specific opioid recognition pharmacophore recently developed. The comparison provided identification of the additional requirements for activation of delta, mu, and kappa opioid receptors. The distance analysis approach was able to clearly discriminate kappa-agonists, while global molecular properties for all compounds were calculated to identify additional requirements for activation of delta and mu receptors. Comparisons of the combined geometric and physicochemical properties calculated for each of the three sets of agonists allowed the determination of unique requirements for activation of each of the three opioid receptors. These results can be used to improve the activation selectivity of known opioid agonists and as a guide for the identification of novel selective opioid ligands with potential therapeutic usefulness.

Mesh:

Substances:

Year:  2001        PMID: 11349813     DOI: 10.1023/a:1011187320095

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  34 in total

1.  3D modeling, ligand binding and activation studies of the cloned mouse delta, mu; and kappa opioid receptors.

Authors:  M Filizola; L Laakkonen; G H Loew
Journal:  Protein Eng       Date:  1999-11

Review 2.  A molecular basis for opiate action.

Authors:  D Massotte; B L Kieffer
Journal:  Essays Biochem       Date:  1998       Impact factor: 8.000

Review 3.  Opioid analgesics.

Authors:  P J Pascoe
Journal:  Vet Clin North Am Small Anim Pract       Date:  2000-07       Impact factor: 2.093

4.  Cloning of a delta opioid receptor by functional expression.

Authors:  C J Evans; D E Keith; H Morrison; K Magendzo; R H Edwards
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

5.  Characterization of the bioactive form of linear peptide antagonists at the omega-opioid receptor.

Authors:  T M Chao; J J Perez; G H Loew
Journal:  Biopolymers       Date:  1996-06       Impact factor: 2.505

Review 6.  Opiate tolerance and dependence: receptors, G-proteins, and antiopiates.

Authors:  L M Harrison; A J Kastin; J E Zadina
Journal:  Peptides       Date:  1998       Impact factor: 3.750

7.  Conformational energy penalties of protein-bound ligands.

Authors:  J Boström; P O Norrby; T Liljefors
Journal:  J Comput Aided Mol Des       Date:  1998-07       Impact factor: 3.686

8.  Comparative modeling and molecular dynamics studies of the delta, kappa and mu opioid receptors.

Authors:  D Strahs; H Weinstein
Journal:  Protein Eng       Date:  1997-09

9.  Primary structures and expression from cDNAs of rat opioid receptor delta- and mu-subtypes.

Authors:  K Fukuda; S Kato; K Mori; M Nishi; H Takeshima
Journal:  FEBS Lett       Date:  1993-08-02       Impact factor: 4.124

10.  Molecular docking reveals a novel binding site model for fentanyl at the mu-opioid receptor.

Authors:  G Subramanian; M G Paterlini; P S Portoghese; D M Ferguson
Journal:  J Med Chem       Date:  2000-02-10       Impact factor: 7.446

View more
  8 in total

Review 1.  Homology modeling of opioid receptor-ligand complexes using experimental constraints.

Authors:  Irina D Pogozheva; Magdalena J Przydzial; Henry I Mosberg
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

2.  Chemical function-based pharmacophore generation of selective kappa-opioid receptor agonists by catalyst and phase.

Authors:  Jing Zhang; Guixia Liu; Yun Tang
Journal:  J Mol Model       Date:  2009-02-11       Impact factor: 1.810

3.  Consensus 3D model of μ-opioid receptor ligand efficacy based on a quantitative Conformationally Sampled Pharmacophore.

Authors:  Jihyun Shim; Andrew Coop; Alexander D MacKerell
Journal:  J Phys Chem B       Date:  2011-05-12       Impact factor: 2.991

4.  Allosteric modulation model of the mu opioid receptor by herkinorin, a potent not alkaloidal agonist.

Authors:  A F Marmolejo-Valencia; K Martínez-Mayorga
Journal:  J Comput Aided Mol Des       Date:  2017-03-31       Impact factor: 3.686

Review 5.  Designing Safer Analgesics via μ-Opioid Receptor Pathways.

Authors:  H C Stephen Chan; Dillon McCarthy; Jianing Li; Krzysztof Palczewski; Shuguang Yuan
Journal:  Trends Pharmacol Sci       Date:  2017-09-19       Impact factor: 14.819

6.  Insights into subtype selectivity of opioid agonists by ligand-based and structure-based methods.

Authors:  Jianxin Cheng; Guixia Liu; Jing Zhang; Zhejun Xu; Yun Tang
Journal:  J Mol Model       Date:  2010-05-25       Impact factor: 1.810

7.  Activation profiles of opioid ligands in HEK cells expressing delta opioid receptors.

Authors:  Parham Gharagozlou; Hasan Demirci; J David Clark; Jelveh Lameh
Journal:  BMC Neurosci       Date:  2002-11-18       Impact factor: 3.288

8.  Activity of opioid ligands in cells expressing cloned mu opioid receptors.

Authors:  Parham Gharagozlou; Hasan Demirci; J David Clark; Jelveh Lameh
Journal:  BMC Pharmacol       Date:  2003-01-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.